Today: 16 April 2026
Mineral Resources stock rises after director share filings as Jan 29 update nears
10 January 2026
1 min read

Mineral Resources stock rises after director share filings as Jan 29 update nears

Sydney, Jan 10, 2026, 17:43 AEDT — Market closed

Shares of Mineral Resources Ltd (ASX:MIN) closed Friday 1.1% higher at A$57.09, amid new director-share disclosures hitting the market. The stock traded between A$55.66 and A$57.52 during the session.

According to an Appendix 3Y filing — an ASX form revealing shifts in a director’s holdings — the company reported that seven non-executive directors took shares instead of cash for part of their quarterly fees. The notices detail the stock portion was priced at A$55.28 per share, reflecting the five-day volume-weighted average price, with the shares purchased on-market.

The timing is standard, but it comes as MinRes approaches a key operational milestone. The miner, active in lithium, iron ore, energy, and mining services, is set to release its Q2 FY2026 quarterly report on Jan. 29, with half-year results scheduled for Feb. 20.

MinRes is hovering close to the upper end of its 52-week range, which spans from A$14.05 to A$58.64, per MarketWatch data. The stock’s 50-day moving average is roughly A$50.49, and shares have climbed about 61% over the last year, according to Stock Analysis.

Mining stocks grabbed the spotlight after Rio Tinto revealed it’s in early discussions to acquire Glencore, a deal that would crown the combined entity as the world’s largest miner by market cap. Such M&A chatter tends to ripple through the entire resources sector, affecting even those firms not directly involved.

Macro calendars take priority here. China’s December trade balance drops Jan. 14, with the U.S. December CPI following a day earlier, on Jan. 13. These figures have the power to shift the dollar and, in turn, impact commodity prices and miners’ margins.

In its most recent quarterly update from late October, MinRes confirmed it remains on target to hit FY26 volume and cost guidance across all divisions. Onslow Iron shipped 8.6 million tonnes during the quarter. Liquidity stood at $1.1 billion, with net debt at $5.4 billion, following roughly $400 million in capital expenditures.

But this stock tends to react sharply to operational shocks. Back in February 2025, MinRes suffered its worst day in 16 years after slashing iron ore volume forecasts and raising costs at Onslow Iron. Managing director Chris Ellison explained, “These weather events caused significant flooding that damaged parts of the Onslow Iron haul road.” Reuters

Stock Market Today

  • Vedanta Shares Soar to Record High Ahead of Strong Q4 Earnings Forecast
    April 16, 2026, 3:38 AM EDT. Vedanta shares on NSE climbed to a record ₹787.85, extending an 11-day winning streak ahead of their Q4 2026 earnings announcement on April 30. Brokerages project a significant improvement, with EBITDA expected to surge 50-60% year-on-year, driven by robust commodity prices and cost efficiencies. Motilal Oswal anticipates a 22.8% rise in consolidated revenue and a 155% increase in net profit year-on-year. Nuvama, ICICI Securities, and Kotak Securities also forecast substantial quarterly growth, highlighting strengths in aluminium, zinc, and oil & gas segments. Kotak assigned a buy rating, targeting ₹890 per share. The outlook signals strong momentum as Vedanta capitalizes on favorable market dynamics and operational gains.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 16.04.2026

16 April 2026
LIVEMarkets rolling coverageStarted: April 16, 2026, 12:00 AM EDTUpdated: April 16, 2026, 3:41 AM EDT Vedanta Shares Soar to Record High Ahead of Strong Q4 Earnings Forecast April 16, 2026, 3:38 AM EDT. Vedanta shares on NSE climbed to a record ₹787.85, extending an 11-day winning streak ahead of their Q4 2026 earnings announcement on April 30. Brokerages project a significant improvement, with EBITDA expected to surge 50-60% year-on-year, driven by robust commodity prices and cost efficiencies. Motilal Oswal anticipates a 22.8% rise in consolidated revenue and a 155% increase in net profit year-on-year. Nuvama, ICICI Securities, and Kotak Securities
Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

16 April 2026
Norse Atlantic Airways has canceled all planned summer flights from Los Angeles to London Gatwick, Paris, and Rome, citing surging jet fuel costs. The airline launched a $110 million rights issue, secured a $70 million bridge loan, and withdrew its 2026 outlook. Routes disappeared from booking systems on April 14. Norse had been the only scheduled operator on the Gatwick-Los Angeles route.
S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

16 April 2026
The S&P 500 closed at a record 7,022.95 and the Nasdaq at 24,016.02 on Wednesday, erasing losses from the March selloff tied to the Feb. 28 conflict. Bank of America reported $8.6 billion in first-quarter net income, up 17%, while Morgan Stanley posted record revenue. Talks between Washington and Tehran raised hopes for easing oil supply fears, but Brent crude stayed elevated at $94.93 a barrel.
Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

16 April 2026
China is considering export restrictions on advanced solar-manufacturing equipment to the U.S., potentially affecting Tesla’s plans for new factories, sources told Reuters. Tesla aims to buy $2.9 billion in solar-panel equipment from China and expand U.S. solar production. China produces over 80% of global solar panel components. No final decision has been made, and consultations remain preliminary.
Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

15 April 2026
Hims & Hers Health shares rose 14% to $24.29 after the FDA said it will review restrictions on several peptides, including BPC-157 and TB-500. The agency set a July advisory meeting and will remove some peptides from its safety-risk list within a week. Hims, which acquired a California peptide facility last year, reported $2.35 billion in 2025 revenue and 2.511 million subscribers.
Zip Co stock ends week up 4% as traders turn to Feb results and US growth
Previous Story

Zip Co stock ends week up 4% as traders turn to Feb results and US growth

Wilmar International stock heads into Monday as Indonesia levy talk and food prices reset the lens
Next Story

Wilmar International stock heads into Monday as Indonesia levy talk and food prices reset the lens

Go toTop